Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 167, Issue 4, Pages 487-499
Publisher
Wiley
Online
2014-09-08
DOI
10.1111/bjh.13066
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Physiological Modulation Approaches to Improve Cancer Chemotherapy : A Review
- (2014) Rajesh Kumar et al. Anti-Cancer Agents in Medicinal Chemistry
- Potential clinical applications of bimodal PET-MRI or SPECT-MRI agents
- (2014) Rafael T. M. de Rosales JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Polyethyleneimine-functionalized iron oxide nanoparticles for systemic siRNA delivery in experimental arthritis
- (2014) Juanli Duan et al. Nanomedicine
- Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
- (2013) Roy van der Meel et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting CD22 in B-cell Malignancies: Current Status and Clinical Outlook
- (2013) Loretta Sullivan-Chang et al. BIODRUGS
- Chronic lymphocytic leukaemia - the role of the microenvironment pathogenesis and therapy
- (2013) Alan D. Ramsay et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical Nanomedicine: A Solution to the Chemotherapy Conundrum in Pediatric Leukemia Therapy
- (2013) V Krishnan et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Targeted therapy with monoclonal antibodies in acute lymphoblastic leukemia
- (2013) Dieter Hoelzer CURRENT OPINION IN ONCOLOGY
- Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions
- (2013) Keith J. August et al. DRUGS
- An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies
- (2013) Patricia Zerra et al. EXPERT OPINION ON PHARMACOTHERAPY
- The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients
- (2013) Andreas Hochhaus et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Acute Promyelocytic Leukemia: Do We Have a New Front-Line Standard of Treatment?
- (2013) Miguel A. Sanz et al. Current Oncology Reports
- Novel Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia – A Focus on Emerging Monoclonal Antibodies
- (2013) Naval Daver et al. Current Hematologic Malignancy Reports
- Treatment of infant leukemias: challenge and promise
- (2013) P. Brown Hematology-American Society of Hematology Education Program
- Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
- (2012) W. Haso et al. BLOOD
- The future role of monoclonal antibody therapy in childhood acute leukaemias
- (2012) Matthew Barth et al. BRITISH JOURNAL OF HAEMATOLOGY
- Perspectives on the causes of childhood leukemia
- (2012) Joseph Wiemels CHEMICO-BIOLOGICAL INTERACTIONS
- Molecular genetics of B-precursor acute lymphoblastic leukemia
- (2012) Charles G. Mullighan JOURNAL OF CLINICAL INVESTIGATION
- Efficacy of a CD22-targeted antibody-saporin conjugate in a xenograft model of precursor-B cell acute lymphoblastic leukemia
- (2012) Jason Kato et al. LEUKEMIA RESEARCH
- Nanoparticle ζ -Potentials
- (2011) Tennyson L. Doane et al. ACCOUNTS OF CHEMICAL RESEARCH
- A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia
- (2011) John Schindler et al. BRITISH JOURNAL OF HAEMATOLOGY
- Antibody Fusion Proteins: Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox
- (2011) R. J. Kreitman et al. CLINICAL CANCER RESEARCH
- Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer
- (2011) Liangqian Tong et al. Frontiers of Medicine
- Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia
- (2010) Francis Mussai et al. BRITISH JOURNAL OF HAEMATOLOGY
- Chemoimmunotherapy With a Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome–Negative Precursor B-Lineage Acute Lymphoblastic Leukemia
- (2010) Deborah A. Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- Multifunctional Nanomedicine Platform for Cancer Specific Delivery of siRNA by Superparamagnetic Iron Oxide Nanoparticles-Dendrimer Complexes
- (2010) Oleh Taratula et al. Current Drug Delivery
- Simultaneous Inference in General Parametric Models
- (2008) Torsten Hothorn et al. BIOMETRICAL JOURNAL
- Generalized Maximally Selected Statistics
- (2008) Torsten Hothorn et al. BIOMETRICS
- Acute lymphoblastic leukaemia
- (2008) Ching-Hon Pui et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search